Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Press Release – ZIM Lab Invests in Key Partnerships in Australia and MENA
2023
This is some text inside of a div block.
Drug Delivery Solution Provider, ZIM Laboratories Limited lists on NSE.
2022
This is some text inside of a div block.
Press Release - NSE Listing
2022
This is some text inside of a div block.
ZIM Laboratories Limited and Neuraxpharm enter into an exclusive co-development agreement
2019
This is some text inside of a div block.
ZIM Laboratories Limited and Hypera Pharma Group enter into an exclusive licensing agreement of Vitamin D3 Orally Disintegrating Strips for Brazil Market
2020
This is some text inside of a div block.
ZIM Laboratories Limited has been granted marketing authorization for Sildenafil 50 mg ODS by AEMPS - The Spanish Agency for Medicine and Healthcare Products, for its European subsidiaries.
2022
This is some text inside of a div block.
Zim Laboratories Limited has been granted marketing rights for Rizatriptan by Infarmed, for its European subsidiaries.
.svg)
